Compare Stocks: CYCC, MWYN, RECT, and TLIH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYCC Cyclacel Pharmaceuticals	$6.37	$7.23	$0.22 ▼ $19.87	$14.26M	0.15	3.54 million shs	N/A
MWYN Marwynn	$1.10	$1.00	$0.45 ▼ $1.44	$22.21M	3.94	86,429 shs	40,639 shs
RECT Rectitude	$1.29 +0.4%	$1.27	$0.96 ▼ $4.45	$19.83M	1	2,755 shs	4,337 shs
TLIH Ten-League International	$5.68	$5.76	$2.20 ▼ $6.74	$16.70M	2.38	2,480 shs	9,624 shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYCC Cyclacel Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-1.16%
MWYN Marwynn	0.00%	+13.95%	-14.06%	+5.77%	-1.79%
RECT Rectitude	0.00%	+0.31%	+0.78%	+5.33%	-66.01%
TLIH Ten-League International	0.00%	-3.34%	-1.90%	+17.84%	+1.92%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CYCC Cyclacel Pharmaceuticals	$6.37	$7.23	$0.22 ▼ $19.87	$14.26M	0.15	3.54 million shs	N/A
MWYN Marwynn	$1.10	$1.00	$0.45 ▼ $1.44	$22.21M	3.94	86,429 shs	40,639 shs
RECT Rectitude	$1.29 +0.4%	$1.27	$0.96 ▼ $4.45	$19.83M	1	2,755 shs	4,337 shs
TLIH Ten-League International	$5.68	$5.76	$2.20 ▼ $6.74	$16.70M	2.38	2,480 shs	9,624 shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CYCC Cyclacel Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	-1.16%
MWYN Marwynn	0.00%	+13.95%	-14.06%	+5.77%	-1.79%
RECT Rectitude	0.00%	+0.31%	+0.78%	+5.33%	-66.01%
TLIH Ten-League International	0.00%	-3.34%	-1.90%	+17.84%	+1.92%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CYCC Cyclacel Pharmaceuticals	0.00	N/A	N/A	N/A
MWYN Marwynn	1.00	Sell	N/A	N/A
RECT Rectitude	1.00	Sell	N/A	N/A
TLIH Ten-League International	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest CYCC, MWYN, RECT, and TLIH Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/28/2026	RECT Rectitude	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
9/21/2026	MWYN Marwynn	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
9/11/2026	RECT Rectitude	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D+) ➝ Sell (D)
8/26/2026	RECT Rectitude	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D) ➝ Sell (D+)
8/3/2026	TLIH Ten-League International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
7/24/2026	RECT Rectitude	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)

(Data available from 10/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CYCC Cyclacel Pharmaceuticals	$40K	356.44	N/A	N/A	($58.87) per share	-0.11
MWYN Marwynn	$4.24M	5.24	N/A	N/A	$0.13 per share	8.46
RECT Rectitude	$39.74M	0.50	$0.23 per share	5.60	$1.50 per share	0.86
TLIH Ten-League International	$59.24M	0.28	$2.72 per share	2.09	$4.42 per share	1.29

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CYCC Cyclacel Pharmaceuticals	-$11.21M	-$839.58	N/A	N/A	N/A	N/A	-723.64%	-145.51%	N/A
MWYN Marwynn	-$3.92M	-$0.07	N/A	N/A	N/A	-24.74%	-29.11%	-14.05%	N/A
RECT Rectitude	$2.78M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLIH Ten-League International	$4.34M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest CYCC, MWYN, RECT, and TLIH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/30/2026	Q2 2026	TLIH Ten-League International	N/A	$0.23	N/A	$0.23	N/A	$12.79 million
9/14/2026	Q1 2027	MWYN Marwynn	N/A	-$0.01	N/A	-$0.0050	N/A	$1.09 million
7/30/2026	Q4 2026	MWYN Marwynn	N/A	$0.02	N/A	$0.02	N/A	$2.77 million
7/30/2026	Q4 2026	RECT Rectitude	N/A	$0.03	N/A	$0.0250	N/A	$10.47 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CYCC Cyclacel Pharmaceuticals	N/A	N/A	N/A	N/A	N/A
MWYN Marwynn	N/A	N/A	N/A	N/A	N/A
RECT Rectitude	$0.10	7.78%	N/A	N/A	N/A
TLIH Ten-League International	N/A	N/A	N/A	N/A	N/A

Latest CYCC, MWYN, RECT, and TLIH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/5/2026	RECT Rectitude		$0.10		9/4/2026	9/7/2026	9/21/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CYCC Cyclacel Pharmaceuticals	N/A	5.77	5.77
MWYN Marwynn	N/A	4.94	4.94
RECT Rectitude	0.15	2.53	1.93
TLIH Ten-League International	0.37	0.80	0.64

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CYCC Cyclacel Pharmaceuticals	23.58%
MWYN Marwynn	N/A
RECT Rectitude	N/A
TLIH Ten-League International	N/A

Insider Ownership

Company	Insider Ownership
CYCC Cyclacel Pharmaceuticals	51.20%
MWYN Marwynn	29.78%
RECT Rectitude	N/A
TLIH Ten-League International	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CYCC Cyclacel Pharmaceuticals	14	2.24 million	1.09 million	Optionable
MWYN Marwynn	27	20.19 million	14.18 million	N/A
RECT Rectitude	145	15.43 million	N/A	N/A
TLIH Ten-League International	70	2.94 million	N/A	N/A

CYCC, MWYN, RECT, and TLIH Headlines

Recent News About These Companies

Ten-League International (NASDAQ:TLIH) Releases Quarterly Earnings Results

October 2 at 7:26 AM | americanbankingnews.com

Ten-League International Holdings Limited Reports Unaudited Financial Results for the First Six Months of Fiscal Year 2026

September 30, 2026 | globenewswire.com

Ten-League International Holdings Limited Announces Grand Opening of Expanded Singapore Headquarters

August 19, 2026 | globenewswire.com

Ten-League Regains Nasdaq Bid Price Compliance, Remains Under One-Year Listing Monitor

June 1, 2026 | tipranks.com

Ten-League International Holdings Limited Regains Compliance with Nasdaq Bid Price Requirement

June 1, 2026 | globenewswire.com

Ten-League International Holdings Limited Reports Fiscal Year 2025 Financial Results

April 30, 2026 | globenewswire.com

Ten-League International Holdings Limited Announces 1-for-10 Reverse Share Split Effective May 1, 2026

April 29, 2026 | globenewswire.com

Ten-League International Wins Shareholder Approval for Flexible Share Consolidation Plan

April 13, 2026 | tipranks.com

Ten-League International Holdings Limited Faces Potential Delisting from Nasdaq Following Non-Compliance with Minimum Bid Price Rule

March 16, 2026 | quiverquant.comQ

Ten-League International Holdings Limited Announces Receipt of Nasdaq Staff Delisting Determination and Plans to Appeal

March 16, 2026 | globenewswire.com

Ten-League International forecasts strong FY2025 growth on Singapore infrastructure momentum

February 24, 2026 | msn.com

Ten-League International Issues Strong FY2025 Guidance on Singapore Infrastructure Demand

February 24, 2026 | tipranks.com

Why Is Ten-League International Holdings Limited Stock (TLIH) Up Today?

February 24, 2026 | tipranks.com

Ten-League International Holdings Limited Announces Fiscal Year 2025 Guidance

February 24, 2026 | globenewswire.com

Ten-League International Holdings Limited Completes Handover of Hydraulic Grabs for Land Transport Authority's Cross Island Line Project

December 19, 2025 | quiverquant.comQ

Ten-League Completes Hydraulic Grab Handover for Singapore’s Cross Island MRT Line

December 19, 2025 | tipranks.com

Ten-League International Holdings Limited Announces Project Handover to Bachy Soletanche Singapore

December 19, 2025 | globenewswire.com

Ten-League International Appoints New Auditor Amid Smooth Transition

December 12, 2025 | tipranks.com

Ten-League Secures New Order from PSA Singapore to Enhance Port Electrification

November 14, 2025 | tipranks.com

Ten-League International Holdings Limited Announces New Order from PSA Singapore to Expand Electrification Program Following Successful BCSS Deployment

November 14, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CYCC, MWYN, RECT, and TLIH Company Descriptions

Cyclacel Pharmaceuticals NASDAQ:CYCC

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey.

Marwynn NASDAQ:MWYN

$1.10 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$1.17 +0.07 (+6.27%)

As of 08:08 AM Eastern

Marwynn Holdings, Inc. is a holding company with no operations other than holding the shares of its two wholly-owned operating subsidiaries, FuAn Enterprise, Inc. (“FuAn”) and Grand Forest Cabinetry Inc (“Grand Forest”), that are in the supply chain business. Through our subsidiaries, we are committed to becoming a leading supply chain company in the U.S. for food, non-alcoholic beverages and indoor home improvement products. Food and Non-Alcoholic Beverages FuAn is a food and non-alcoholic beverage supply chain company that specializes in connecting businesses between different regions, particularly between Asia and the U.S. FuAn’s comprehensive supply chain services include the sourcing of Asian food, snacks, and non-alcoholic beverages, and distributing branded goods to mainstream markets, grocery stores and wholesale/warehouse clubs in the U.S. In addition, FuAn provides supply chain consulting, and market expansion support for businesses. With a focus on sourcing Asian foods and non-alcoholic beverages, FuAn aims at becoming a leading importer and distributor of Asian foods and non-alcoholic beverages to the U.S. markets. --- Indoor Home Improvement Grand Forest is an indoor home improvement supply chain provider that focuses on providing kitchen cabinets, flooring, and home improvement products sourced from international suppliers. Grand Forest strives to bring affordable luxury with both aesthetics and practicality to the living space. We focus on sourcing high-quality products from reliable overseas suppliers and distributing them to customers primarily in the San Francisco Bay Area, as we work to expand our capabilities throughout California and across the U.S. We prioritize customer satisfaction and aim to provide exceptional products and services to enhance the homes of our customers. Our principal executive office is located in Irvine, CA.

Rectitude NASDAQ:RECT

$1.28 +0.01 (+0.39%)

Closing price 10/2/2026 03:58 PM Eastern

Extended Trading

$1.33 +0.04 (+3.42%)

As of 08:59 AM Eastern

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, gloves, safety footwear, personal fall arrest systems, portable fire extinguishers and traffic products. The Company also offers auxiliary products such as industrial hardware tools and electrical hardware required for construction sites. Rectitude Holdings Ltd is based in SINGAPORE.

Ten-League International NASDAQ:TLIH

$5.68 0.00 (0.00%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$5.68 0.00 (-0.09%)

As of 10/2/2026 07:30 PM Eastern

Our mission is to provide high-quality equipment, value-added engineering solutions as well as maintenance and repair services through continuous adaptation and application of new technologies. We are a Singapore-based provider of turnkey project solutions. Our business primarily consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. We currently conduct our operations through our wholly-owned subsidiaries, Ten-League Engineering & Technology Pte. Ltd., or Ten-League (E&T), and Ten-League Port Engineering Solutions Pte. Ltd., or Ten-League (PES), which were previously held by Ten-League Corp prior to our group reorganization for the listing of our ordinary shares. Together with the operating history of Ten-League Corp, we have a total of over 25 years of history operating our business. Our core business activities consist of the following segments: (a) equipment sales, which involves sale of various new and used heavy equipment and parts, or Equipment Sales Business; (b) equipment rental, which involves the rental of various new and used heavy equipment, or Equipment Rental Business; and (c) engineering consultancy services, which primarily includes the provision of value-added engineering solutions, including equipment retrofitting, upgrading, modernization, fleet management and other enhancement on equipment through the replacement or application of, among others, mechanical parts, sensor fusion, software and remote control system. Our engineering consultancy services complements our Equipment Sales Business and Equipment Rental Business. We do not provide such service to third-party equipment sales/rental companies. The equipment we provide is categorized into (i) foundation equipment; (ii) hoist equipment; (iii) excavation equipment; and (iv) port machinery. We have been supplying fully electric reach stacker and empty container handler to port operators in Singapore since 2021 and have been contracted to supply electric prime movers with swappable battery pack and build charging infrastructure since October 2022 by a leading port operator based in Singapore, or the Leading Port Operator. Meanwhile, we are actively exploring the market for fully electric wheel loader, excavator and forklift, and offering them as a part of our fleet of electrified equipment. Our principal executive office is in Singapore.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CYCC, MWYN, RECT, and TLIH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CYCC, MWYN, RECT, and TLIH Earnings

Compare Dividends

Latest CYCC, MWYN, RECT, and TLIH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CYCC, MWYN, RECT, and TLIH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

CYCC, MWYN, RECT, and TLIH Company Descriptions

Cyclacel Pharmaceuticals NASDAQ:CYCC

Marwynn NASDAQ:MWYN

Rectitude NASDAQ:RECT

Ten-League International NASDAQ:TLIH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools